Staying within the boundaries.
As psychiatrists, it behooves us to view this as a boundary issue, as we do with patients. Although it is a fact of life that physicians will be paid for rendering services to drug companies, we should handle it the same way we do with sex and our patients: We don't belong in bed with them.
My last remuneration for a drug study was more than 45 years ago, when I tested a combination of dioxolane and reserpine. When I reported that the side effects were greater than the salutary effects, I heard no more from the company! Incidentally, a professor at another university published a positive report. The product was never marketed.
Sheldon B. Cohen, M.D.